On a broiler production site using a 1:50 venturi proportioner, Lianhuang Granules veterinary grade API is added to a stainless steel stock tank at a ratio of 0.5–2.0 g/L of non-chlorinated water held at 20–25 °C; the suspension is recirculated for 30 min before the proportioner injects the stock solution into the main drinking line. The dissolution step is not passive: the API is first wetted with a 1:3 water pre-mix and dispersed with a high-shear impeller operating at 1,000–1,500 rpm until no visible granule aggregates remain; the resulting slurry is passed through a 45 µm in-line basket strainer before the proportioner inlet, because undispersed particles clog the proportioner diaphragm and produce dose deviations above 10% across a house. Stock solution temperature is held at 20–25 °C; temperatures below 10 °C slow dissolution and increase viscosity, while temperatures above 35 °C may accelerate oxidative darkening of the flavonoid fraction. Microbial quality of the finished oral solution is controlled according to USP <61> and USP <62>, while the marker alkaloid and flavonoid content is assayed by HPLC with method validation conducted under VICH GL2; system suitability requires a relative standard deviation not exceeding 2.0% for six replicate injections of the standard preparation. Residual free chlorine in the dilution water is maintained below 0.1 ppm because oxidation of the alkaloid fraction accelerates under chlorinated drinking-water conditions. The resulting downstream product is a concentrated oral solution for in-line dilution in poultry drinking-water systems.

What Limits Uniform Dispersal of Lianhuang Granules in Swine Premix Lines?

Medicated premix manufacture in the European market falls under Regulation (EU) 2019/4, which imposes validated homogenisation protocols and cleaning procedures for carryover prevention. On a production-scale line, the API is passed through a 600 µm safety sieve before entering a ribbon mixer with a working volume of 500–2,000 kg; this size reduction step removes extract lumps formed during storage above 60% relative humidity. The sifted API is first extended with ground corn or lactose carrier at a fixed pre-blend ratio of 1:10 by mass and mixed for 10 min in an intermediate bin, then incorporated into the complete premix to reach a final inclusion rate of 0.5–5.0 kg per tonne of finished feed, adjusted by assay to the marker content required by the prescription. Typical addition sequence loads half of the carrier first, then the pre-blend, then the remaining carrier; this layered loading reduces segregation during the initial mixing revolution and shortens the time to coefficient-of-variation convergence. Ribbon speed is maintained at 20–30 rpm for the working volume and discharge is completed within 15 min to limit static charge accumulation. Homogeneity is verified by collecting 10 samples from the discharge stream and assaying the marker compound by HPLC; batch acceptance requires a coefficient of variation below 5.0%, with sampling performed according to ISO 6497:2002. Carryover into non-medicated batches is controlled by physical cleaning of mixer paddles and dust extraction filters after each run, because residual fine concentrate adheres to internal surfaces and can contaminate subsequent unmedicated feed. Terminal finished product type: medicated premix for either mash or pelleted swine feed.

Terminal moist-heat sterilisation at 121 °C for 15 min is evaluated for lot-to-lot consistency when Lianhuang Granules veterinary grade API is formulated as an injectable solution for cattle. The aqueous vehicle is prepared with Water for Injection, and the API is dissolved at 1.0–10.0 g/100 mL while the pH is adjusted to pH 5.5–7.0 with a phosphate buffer; because the natural extract buffer capacity varies between harvest batches, the titratable alkali demand of each API lot is measured before bulk compounding. During bulk compounding, the API is added under high-shear mixing to the phosphate-buffered vehicle at 25–30 °C, and the bulk solution is held for 60 min with continuous stirring before the first filtration pass; this hydration period releases entrapped air from the extract granule pores and reduces foaming during filling. The solution is clarified by passage through a 0.45 µm depth filter and then sterilised by filtration through a 0.22 µm membrane; thereafter it is filled into amber Type I glass vials under nitrogen sparging that reduces dissolved oxygen to below 0.5 ppm and slows oxidative degradation of the flavonoid fraction. Sterility is confirmed by direct inoculation under USP <71>, and bacterial endotoxin content is controlled to not more than 0.5 EU/mg of API according to USP <85>. A processing boundary exists: autoclaving of the final filled solution is avoided when the pH exceeds 7.0 because alkaline hydrolysis of the marker alkaloids accelerates and produces visible precipitation. The terminal dosage form is a sterile injectable solution for parenteral administration in cattle.

When Tablets and Capsules Are Compressed from Lianhuang Granules

Direct compression is not used when the API fraction exceeds 40% of tablet mass because the granulated extract exhibits poor flow and high hygroscopicity; a wet granulation route is therefore selected for companion animal dosage forms. The API is blended with microcrystalline cellulose and croscarmellose sodium in a high-shear granulator, wetted with purified water until a 10–20% w/w moisture level is reached, and dried in a fluid-bed dryer at 45–55 °C until loss on drying is 3.0–5.0%. Granulation end point is determined by impeller power consumption rather than fixed time, because the natural polysaccharide components in the extract alter wet mass rheology from batch to batch. The dried mass is milled through a 1.0 mm screen and lubricated with magnesium stearate at 0.5–1.0% w/w, then compressed into 400 mg tablets that contain 50–200 mg of API per unit; tablet hardness is maintained at 50–80 N to satisfy disintegration requirements under USP <701> and content uniformity under USP <905>. For capsule filling, size 0 or size 1 hard gelatin capsules receive a granule fill of 250–400 mg, and dissolution is run in 900 mL of pH 6.8 phosphate buffer using USP <711> Apparatus II at 50 rpm, with not less than 75% of marker compounds released at 45 min. Packaging is specified in aluminium-PVC/PVDC blisters when ambient relative humidity exceeds 60%, because moisture uptake above this value changes tablet hardness and causes surface spotting of the extract. The terminal dosage form is a tablet or hard gelatin capsule for oral administration to companion animals.

Water-soluble powder manufacturing for broiler medication is limited by the dissolution rate of the granulated extract in cold drinking water at 15–25 °C. The API is milled to a particle size distribution in which 90% of particles pass a 500 µm sieve according to ISO 6497:2002, then blended with anhydrous glucose or lactose carrier in a V-type mixer at an API-to-carrier mass ratio of 1:20 to 1:5, depending on the final marker delivery stated in the veterinary prescription. Mixing beyond 30 min is avoided because the low-moisture blend builds electrostatic charge, causing fines to adhere to the mixer walls and reducing discharge uniformity. The finished powder is filled into polyethylene-lined paper bags and heat-sealed immediately; the filled bag headspace is reduced to below 5% by volume before sealing to limit moisture ingress, and silica gel desiccant sachets are inserted when ambient relative humidity exceeds 65%. Batch release requires HPLC assay at 270 nm after methanolic extraction, with acceptance limits tied to the dried extract marker content. The resulting downstream product is a water-soluble powder for reconstitution in poultry drinking water.

Fluidised-Bed Granulation Transfers Lianhuang Granules into Low-Dust Oral Granules

Low-dust oral granules for calves and sows are produced by top-spray fluidised-bed granulation using a hydroxypropyl methylcellulose binder solution at 2.0–5.0% w/v. Inlet air temperature is maintained at 55–65 °C, product temperature at 30–40 °C, and spray rate is set to 10–20 g/min per kg of API; atomising air pressure is held at 1.5–2.5 bar to prevent nozzle blockage by the tacky extract binder mixture. Filter bag shaking is set to occur every 30 s during spraying to avoid product buildup on the chamber wall. The resulting granules achieve a bulk density of 0.65–0.85 g/cm³ and a friability below 1.0% after 10 min in a rotating drum apparatus. The granulated API is subsequently blended with unmedicated feed at a mass ratio of 1:100 to 1:10 for top-dressing, although the granule itself remains the sole active component. Impurity and degradation product limits are established according to VICH GL18; under accelerated storage at 40 °C/75% RH for 6 months, total impurities remain below 2.0% area normalisation in the HPLC chromatogram, though published long-term data for this specific extract in low-dust oral granules is limited. Non-sterile oral microbial quality is assessed by Ph. Eur. 2.6.12 and Ph. Eur. 2.6.13. Terminal finished product type: low-dust oral granules for top-dressing onto solid feed or for oral drench after reconstitution.